Search
01/06/2025
Robotic ileal ureter replacement vs kidney autotransplantation for long ureteric strictures
Afferi, L, Gallioli, A, Territo, A, Cannoletta, D, Mestdagh, K, Vangeneugden, J, Van Praet, C, Desender, L, Mercier, J, Prudhomme, T, Salamone, V, Fontana, G, Albisinni, S, Osswald, R, John, H, Etcheverry, B, Vigués, F, Doumerc, N, Minervini, A, Palou, J, Decaestecker, K, Breda, A. Robotic ileal ureter replacement vs kidney autotransplantation for long ureteric strictures. BJU INTERNATIONAL. 2025; 135(6)DOI:10.1111/bju.16704. PMID:40066829. IF:4.400(Q1/2D).
01/06/2025
Biological and therapeutic implications of FGFR alterations in urothelial cancer: A systematic review from non-muscle-invasive to metastatic disease
Pichlera, R, van Creija, NCH, Subielab, JD, Cimadamorec, A, Caño-Velascod, J, Tullye, KH, Mori, K, Contieri, R, Afferi, L, Marij, A, Soriak, F, Del Giudice, F, D'Eliam, C, Mayrn, R, Mertensg, LS, Pyrgidiso, N, Moschinip, M, Galliolii, A. Biological and therapeutic implications of FGFR alterations in urothelial cancer: A systematic review from non-muscle-invasive to metastatic disease. Actas Urologicas Espanolas. 2025; 49(5)DOI:10.1016/j.acuro.2025.501719. PMID:39955055. IF:1.200(Q3/7D).
01/06/2025
Robot-assisted kidney transplantation using right- vs. left-sided grafts from living donors: a prospective multicenter study from the ERUS-RAKT working group
Pecoraro, A, Territo, A, Gallioli, A, Basile, G, Vangeneugden, J, Etcheverry, B, Era, MM, Rodriguez, BLD, Prudhomme, T, Mercier, J, Ortved, M, Chner, PZ, Volpe, A, Garcia-baquero, R, Kocak, B, Idu, M, Stockle, M, Rohrsted, M, Canda, AE, Roder, A, Alcaraz, A, Doumerc, N, Vigues, F, Decaestecker, K, Masieri, L, Serni, S, Breda, A, Campi, R. Robot-assisted kidney transplantation using right- vs. left-sided grafts from living donors: a prospective multicenter study from the ERUS-RAKT working group. Minerva Urology And Nephrology. 2025; 77(3)DOI:10.23736/S2724-6051.25.06279-2. PMID:40528772. IF:4.200(Q1/2D).
01/06/2025
Impact of opium on bladder cancer incidence: A systematic review and meta-analysis
Mancon, S, Matsukawa, A, Cadenar, A, Tsuboi, I, Miszczyk, M, Parizi, MK, Fazekas, T, Schulz, RJ, Cormio, A, Laukhtina, E, Gallioli, A, Diana, P, Contieri, R, Soria, F, Pradere, B, Lughezzani, G, Kimura, T, Territo, A, Breda, A, Buffi, NM, Hurle, R, Shariat, SF, D'Andrea, D. Impact of opium on bladder cancer incidence: A systematic review and meta-analysis. Actas Urologicas Espanolas. 2025; 49(5)DOI:10.1016/j.acuro.2025.501749. PMID:40097099. IF:1.200(Q3/7D).
01/06/2025
A Global Perspective on the Adoption of Different Robotic Platforms in Uro-Oncological Surgery
Cannoletta, D, Gallioli, A, Mazzone, E, Sopena, JMG, Territo, A, Di Bello, F, Casadevall, M, Mas, L, Mancon, S, Diana, P, Palou, J, Breda, A. A Global Perspective on the Adoption of Different Robotic Platforms in Uro-Oncological Surgery. European Urology Focus. 2025; 11(1)DOI:10.1016/j.euf.2025.03.016. PMID:40158899. IF:5.600(Q1/1D).
01/06/2025
Reirradiation Practice in Gynecological Cancer: Insights from a National Survey in Spain
Najjari-Jamal, D, Rovirosa, A, Gimeno-Morales, M, Majercakova, K, Sánchez, M, Garcia, S, Guevara, D, Muñoz, T, de la Fuente, C, Micó, S, Stefanovic, M, Matute, R, Córdoba, S. Reirradiation Practice in Gynecological Cancer: Insights from a National Survey in Spain. Clinical & Translational Oncology. 2025; 27(6)DOI:10.1007/s12094-024-03804-x. PMID:39636497. IF:2.500(Q3/6D).
01/06/2025
Mediterranean Diet and Risk of Hip Fracture: A Systematic Review and Dose-Response Meta-Analysis
Fa-Binefa, M, Clara, A, Lamas, C, Elosua, R. Mediterranean Diet and Risk of Hip Fracture: A Systematic Review and Dose-Response Meta-Analysis. NUTRITION REVIEWS. 2025; 83(6)DOI:10.1093/nutrit/nuae141. PMID:39441714. IF:4.900(Q1/2D).
01/06/2025
Translation and psychometric evaluation of the Spanish version of the Heart Failure-Specific Health Literacy
Santesmases-Masana, R, Hernández-Martínez-Esparza, E, Campillo-Zaragoza, B, Lapena-Estella, C, López, EM, Checa, C, Puig, EG, Paz, LGD. Translation and psychometric evaluation of the Spanish version of the Heart Failure-Specific Health Literacy. PATIENT EDUCATION AND COUNSELING. 2025; 135DOI:10.1016/j.pec.2025.108732. PMID:40081156. IF:3.100(Q1/1D).
01/06/2025
COMPARISON OF ACTIVITY AND REMISSION INDICES IN SYSTEMIC LUPUS ERYTHEMATOSUS: CLINICAL UTILITY
Bernardez, J, Magallares, BP, Codes, H, Martínez-Martínez, L, Gich, I, Castellvi, I, Moya, P, Tandaipan, JL, Park, HS, Díaz-Torné, C, Comas, LS, García-Alija, A, Laiz, A, Fernandez-Sanchez, SP, Ros, S, Corominas, H. COMPARISON OF ACTIVITY AND REMISSION INDICES IN SYSTEMIC LUPUS ERYTHEMATOSUS: CLINICAL UTILITY. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B2893. PMID:. IF:20.600(Q1/1D).
01/06/2025
Measurable Residual Disease in UBTF-TD Adult Acute Myeloid Leukemia
Castellet, H, Ramil, G, Carricondo, M, Oñate, G, Garrido, A, Artigas, A, Pratcorona, M, Salamero, O, Cortés-Bullich, A, Vives, S, Tormo, M, Mascaró, M, Gallardo, D, Tutusaus, JMM, Garcia, A, Sierra, J, Esteve, J, Nomdedéu, J. Measurable Residual Disease in UBTF-TD Adult Acute Myeloid Leukemia. EUROPEAN JOURNAL OF HAEMATOLOGY. 2025; 114(6)DOI:10.1111/ejh.14402. PMID:39988452. IF:2.300(Q2/5D).
01/06/2025
Delphi consensus on referral criteria for pediatric patients with suspected Dravet syndrome
Aledo-Serrano, A, Boronat, S, García-Peñas, JJ, García-Ron, A, Gil-Nagel, A, Uranga, JJR, Sánchez-Carpintero, R, Smeyers, P, Villanueva, V. Delphi consensus on referral criteria for pediatric patients with suspected Dravet syndrome. EPILEPSY & BEHAVIOR. 2025; 167DOI:10.1016/j.yebeh.2025.110401. PMID:40158412. IF:2.300(Q2/4D).
01/06/2025
Telemedicine in critical care
Spies, CD, Ranzani, OT. Telemedicine in critical care. INTENSIVE CARE MEDICINE. 2025; 51(6)DOI:10.1007/s00134-025-07955-5. PMID:40471258. IF:21.200(Q1/1D).
01/06/2025
Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis
Paradies, V, Masiero, G, Rubboli, A, Van Beusekom, HMM, Costa, F, Capranzano, P, Degrauwe, S, Gorog, DA, Jorge, CM, Buchanan, GL, Alasnag, M, Trabattoni, D, Fraccaro, C, Sibbing, D, Dudek, D, Vilahur, G, Chieffo, A, Mehran, R, Capodanno, D, Barbato, E, Siller-Matula, JM. Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis. EuroIntervention. 2025; 21(12)DOI:10.4244/EIJ-D-24-00876. PMID:40388110. IF:9.500(Q1/1D).
01/06/2025
Comprehensive Clinical and Genetic Characterization of a Spanish Cohort of 22 Patients With Bainbridge-Ropers Syndrome
Trujillano, L, Valenzuela, I, Costa-Roger, M, Cusco, I, Fernandez-Alvarez, P, Cueto-Gonzalez, A, Lasa-Aranzasti, A, Masotto, B, Abuli, A, Codina-Sola, M, del Campo, M, Moreno, JAR, Dominguez, CP, Milla, CP, de la Fuente, RP, Quesada-Espinosa, JF, Nunez-Enamorado, N, Gener, B, Ballesta-Martinez, MJ, Brea-Fernandez, AJ, Fernandez-Prieto, M, Trujillo-Quintero, JP, Ruiz, A, Santos-Simarro, F, Rosello, M, Orellana, C, Martinez, F, Martinez-Monseny, AF, Casas-Alba, D, Serrano, M, Palomares-Bralo, M, Rikeros-Orozco, E, Gomez-Cano, MA, Tirado-Requero, P, Juste, JP, Ramos, FJ, Garcia-Arumi, E, Tizzano, EF. Comprehensive Clinical and Genetic Characterization of a Spanish Cohort of 22 Patients With Bainbridge-Ropers Syndrome. CLINICAL GENETICS. 2025; 107(6)DOI:10.1111/cge.14701. PMID:39833101. IF:2.300(Q3/6D).
01/06/2025
Effects of Chronic High-Fat Diet and Pemafibrate Treatment on Stroke Outcomes
Chaparro-Cabanillas, N, Pedragosa, J, Núñez-Moyano, H, Escolà-Gil, JC, Planas, AM. Effects of Chronic High-Fat Diet and Pemafibrate Treatment on Stroke Outcomes. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2025; 45(1)DOI:. PMID:. IF:4.500(Q1/2D).
01/06/2025
Regression of pre-existing white matter hyperintensities after CD19 CAR Tcell induced ICANS: A case series
Borrell-Pichot, M, Lozano, A, Granell, E, Caballero, A, Briones-Mejide, J, Caballero-Avila, M, Vidal-Jordana, A, Querol, L, Mart n-Aguilar, L. Regression of pre-existing white matter hyperintensities after CD19 CAR Tcell induced ICANS: A case series. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025
Exploring results of mechanical thrombectomy in nonagenarians with ischaemic stroke and anterior circulation occlusion
Delgado-Romeu, M, Lopez-Lombardia,O, Carbonell-Fern ndez, P, Morales-Gonz lez, C, Borrell-Pic, M, Martinez-Dome o, A, Guasch-Jim nez, M, Ezcurra-D az, G, Fern ndez-Vidal, J, Prats-S nchez, L, Ramos-Pachn, A, Marti-Fabregas, J, Camps-Renom, P, Lambea-Gil, A. Exploring results of mechanical thrombectomy in nonagenarians with ischaemic stroke and anterior circulation occlusion. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025
Exploring gender disparities in neurology education: Insights from Spanish medical schools
Lambea-Gil, A, Gil-Navarro, S, Jim nez, M, Mart nez-S nchez, P, Mir, P, Oreja-Guevara, C, Pascual-Gomez, J, P rez-Sempere, A, Santos-Lasaosa, S, Frank-Garc a, A, D ez-Tejedor, E. Exploring gender disparities in neurology education: Insights from Spanish medical schools. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025
End-of-life and palliative sedation in the neurology inpatient unit of a tertiary hospital
Morales-Gonz lez, C, Lambea-Gil, A, Barroeta-Espar, I, Olmedo-Saura, G, Prats-S nchez, L, Ramos-Pachon, A, Ros-Castello, V, Vesperina-Castro, A, Mart nez-Dome o, A. End-of-life and palliative sedation in the neurology inpatient unit of a tertiary hospital. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025
Neurophobia and the perception of neurology among neurologists in Spain
Saldana-Inda, I, Lambea-Gil, A. Neurophobia and the perception of neurology among neurologists in Spain. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025
Exploring the Association of Cerebral Vasoreactivity in Patients with Acute Intracerebral Hemorrhage with Functional Outcomes
García, JM, Gil, AL, Pachón, AR, Díaz, GE, Jiménez, MG, Renom, PC, Gómez, MI, Frisk, LK, Vega, CF, Zanoletti, M, Simón, AA, Fabrega, CG, Grifol, NP, Chorro, IM, Sánchez, LP, Vidal, JMF, Fernandez, JJS, Fabregas, JM, Durduran, T. Exploring the Association of Cerebral Vasoreactivity in Patients with Acute Intracerebral Hemorrhage with Functional Outcomes. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2025; 45(1)DOI:. PMID:. IF:4.500(Q1/2D).
01/06/2025
Safety and efficacy data from the phase 2 ARDA study of empasiprubart in multifocal motor neuropathy
Querol, L, Harbo, T, Peric, S, Hussain, Y, Cadour, S, van de Walle, I, Persson, E, Vujcic, M, van de Steen, O, Allen, J, Orazio, EN, Attarian, S, Karam, C, Katzberg, H, Stettner, M, Rinaldi, S, van der Pol, W. Safety and efficacy data from the phase 2 ARDA study of empasiprubart in multifocal motor neuropathy. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025
Safety and efficacy of riliprubart in chronic inflammatory demyelinating polyneuropathy: 76-week phase 2 trial results
Querol, L, Lewis, RA, Hartung, HP, van Doorn, PA, Lin, J, Dionne, A, Attarian, S, Wallstroem, E, Auwarter, K, Lu, Y, Alonso, MA, Atassi, N, Hughes, RAC. Safety and efficacy of riliprubart in chronic inflammatory demyelinating polyneuropathy: 76-week phase 2 trial results. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025
Effect of efgartigimod PH20 SC on lower limb function in chronic inflammatory demyelinating polyneuropathy in ADHERE
Rinaldi, S, Allen, J, Lin, J, Stettner, M, Merkies, I, Guptill, J, Hewamadduma, C, Istas, G, De Roeck, A, Kuwabara, S, Lauria, G, Querol, L, Suresh, N, Karam, C, Skripuletz, T, Echaniz-Laguna, A, Van Hoorick, B, Yamasaki, R, Lewis, R, van Doorn, P. Effect of efgartigimod PH20 SC on lower limb function in chronic inflammatory demyelinating polyneuropathy in ADHERE. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025
Proteomic profiling of Guillain-Barre Syndrome using aptamers: Identifying and Validating Potential Biomarkers
Collet-Vidiella, R, Aguilar, LM, Lleix , C, Caballero-Avila, M, Illa, CT, Go i, EP, Llarch, P, Lluci -Carol, L, Tous, MS, Casasnovas, C, Guti rrez-Guti rrez, G, Fern ndez, JP, Carbayo, A, Gallardo, E, Vesperinas, A, Llanso, L, Fern ndez-Cadenas, I, Querol, L. Proteomic profiling of Guillain-Barre Syndrome using aptamers: Identifying and Validating Potential Biomarkers. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025
Chat-GPT-4o in diagnosis and management of real-life polyneuropathy cases: Comparative analysis with neurologists
De Lorenzo, A, Moretti, G, Bertini, A, Collet-Vidiella, R, Fasolino, A, Fortanier, E, Hadden, R, Islam, B, Kleopa, K, Cejas, LL, Leonardi, L, Mira, V, Peric, S, Rajabally, Y, Sevilla, T, Tomaselli, P, Tozza, S, Pisciotta, C, Pareyson, D, Nobile-Orazio, E, Doneddu, P. Chat-GPT-4o in diagnosis and management of real-life polyneuropathy cases: Comparative analysis with neurologists. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025
Immune checkpoint inhibitor-related myositis-myasthenia: A retrospective cohort study in Spain
Hernandez, EM, Maqueda, JC, Fonseca, E, Marco, C, Chico, J, Fernandez, JG, Llaurado, A, Cabello, J, del Pino, L, Izquierdo, C, Cortes, E, G llego, J, Ros, M, Cald , R, Pelayo, A, Vizcaino, CS, Hernandez, H, Alvarez, J, Simo, M, Dalmau, J, Bruna, J, Velasco, R. Immune checkpoint inhibitor-related myositis-myasthenia: A retrospective cohort study in Spain. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025
Efficacy of Riliprubart in chronic inflammatory demyelinating polyneuropathy: Phase 2 subgroup analyses
Lewis, RA, Querol, L, Hartung, HP, van Doorn, PA, Lin, J, Dionne, A, Attarian, S, Wallstroem, E, Lu, Y, Alonso, MA, Atassi, N, Hughes, AC. Efficacy of Riliprubart in chronic inflammatory demyelinating polyneuropathy: Phase 2 subgroup analyses. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025
Managing multifocal motor neuropathy: A survey of neurologists from Japan, Canada, and six European countries
Querol, L, Lewis, R, Sommer, C, Bromberg, M, Barrera-Sierra, S, Arvin-Berod, C, Nisbet, P, Gelinas, D, Guptill, J, Wood, J. Managing multifocal motor neuropathy: A survey of neurologists from Japan, Canada, and six European countries. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025
Psychometric evaluation of resistance to change questionnaire: reluctance to adopt new treatments in myasthenia gravis
Reyes, V, Maurino, J, Armangu , T, Querol, L, Guti rrez-Guti rrez, G, Sotoca, J, Ares, A, Villaverde, R, Salas, E, D az-Abos, P, Cort s-Vicente, E, Gomez-Ballesteros, R, Ballesteros, J. Psychometric evaluation of resistance to change questionnaire: reluctance to adopt new treatments in myasthenia gravis. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025
Quality of life in patients with generalised myasthenia gravis receiving rozanolixizumab: Post hoc analysis of MycarinG
Sacconi, S, Antozzi, C, Cortes-Vicente, E, Pascuzzi, R, Utsugisawa, K, Vissing, J, Vu, T, Bloemers, J, Grimson, F, Tarancon, T, Bril, V. Quality of life in patients with generalised myasthenia gravis receiving rozanolixizumab: Post hoc analysis of MycarinG. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025
Efgartigimod in pretreated patients with CIDP and progressive/relapsing or persistent disease activity
Skripuletz, T, Allen, J, Rinaldi, S, Lauria, G, Querol, L, Magy, L, De Roeck, A, Van Hoorick, B, Hofman, E, Istas, G, Stettner, M, Lewis, R, van Doorn, P. Efgartigimod in pretreated patients with CIDP and progressive/relapsing or persistent disease activity. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025
Assessment of patient-reported outcomes from the phase 3 vivacity-MG3 study of nipocalimab in gMG
Vicente, EC, Pease, S, Imran, N, Gandhi, K, Ait-Tihuaty, M, Turkoz, I, Coteur, G, Gary, C, Choudhry, Z, Ramchandran, S, Vissing, J. Assessment of patient-reported outcomes from the phase 3 vivacity-MG3 study of nipocalimab in gMG. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025
Herding-like behaviour in myasthenia gravis treatment decisions: exploring underlying mechanisms
Villaverde, R, Gomez-Ballesteros, R, Reyes, V, Armangue, T, Querol, L, Gutierrez-Gutierrez, G, Sotoca, J, Ares, A, Salas, E, Abos, PD, Squaglia, A, Maurino, J, Cortes-Vicente, E. Herding-like behaviour in myasthenia gravis treatment decisions: exploring underlying mechanisms. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025
SUBCUTANEOUS EFGARTIGIMOD PH20 IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: SELECTED SECONDARY OUTCOMES FROM THE ADHERE TRIAL
Lewis, RA, Suresh, N, Mazzeo, A, Allen, JA, Querol, L, Hussain, YM, Gwathmey, KG, Guptill, JT, Istas, G, Van Hoorick, B, Mole, T, Kuwabara, S, Basta, I, van Door, PA. SUBCUTANEOUS EFGARTIGIMOD PH20 IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: SELECTED SECONDARY OUTCOMES FROM THE ADHERE TRIAL. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30DOI:. PMID:. IF:3.200(Q2/4D).
01/06/2025
EFFICACY OF RILIPRUBART IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: PHASE 2 SUBGROUP ANALYSES
Lewis, RA, Querol, L, Hartung, HP, van Doorn, PA, Lin, J, Dionne, A, Attarian, S, Wallstroem, E, Lu, Y, Alonso, MA, Atassi, N, Hughes, RAC. EFFICACY OF RILIPRUBART IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: PHASE 2 SUBGROUP ANALYSES. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30DOI:. PMID:. IF:3.200(Q2/4D).
01/06/2025
SAFETY AND EFFICACY OF RILIPRUBART IN CIDP 76-WEEK PHASE 2 TRIAL RESULTS
Falzone, Y, Querol, L, Lewis, R, Hartung, HP, van Doorn, P, Lin, J, Donnie, A, Attarian, S, Wallstroem, E, Auwarter, K, Lu, Y, Alonso, MA, Atassi, N, Hughes, R. SAFETY AND EFFICACY OF RILIPRUBART IN CIDP 76-WEEK PHASE 2 TRIAL RESULTS. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30DOI:. PMID:. IF:3.200(Q2/4D).
01/06/2025
CHAT-GPT-4O IN DIAGNOSIS AND MANAGEMENT OF REAL-LIFE POLYNEUROPATHY CASES: COMPARATIVE ANALYSIS WITH NEUROLOGISTS
De Lorenzo, A, Moretti, GS, Bertini, A, De Lorenzo, A, Vidiella, RC, Falzone, YM, Fortanier, E, Gendre, T, Gentile, F, Hadden, R, Islam, B, Kleopa, K, Cejas, LL, Leonardi, L, Mandia, D, Marion, M, Mira, V, Peric, S, Querol, L, Rajabally, Y, Sevilla, T, Tomaselli, PJ, Tozza, S, Bosca, M, Brouwer, M, Cocco, A, Cousyn, L, De Santis, T, Gonzalez, F, Lukic, MJ, Mistry, N, Maranzano, A, Morena, E, Nakano, FN, Saura, GO, Sechi, E, Ticozzi, N, Troisi, S, Tsokkos, T, Aymeric, W, Pisciotta, C, Orazio, EN, Pareyson, D, Doneddu, PE. CHAT-GPT-4O IN DIAGNOSIS AND MANAGEMENT OF REAL-LIFE POLYNEUROPATHY CASES: COMPARATIVE ANALYSIS WITH NEUROLOGISTS. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30DOI:. PMID:. IF:3.200(Q2/4D).
01/06/2025
EFFECT OF RITUXIMAB ON NEUROFILAMENT IN CIDP: DATA FROM THE CIDPRIT RANDOMIZED CONTROLLED TRIAL
Gallo, C, Doneddu, PE, Collet-Vidiella, R, Cocito, D, Manganelli, F, Falzone, Y, Pinter, GL, Benedetti, L, Mazzeo, A, Peci, E, Spina, E, Strano, C, Dalla Bella, E, Germano, F, Gentile, L, Liberatore, G, Cutellè, C, Bianchi, E, Querol, L, Nobile-Orazio, E. EFFECT OF RITUXIMAB ON NEUROFILAMENT IN CIDP: DATA FROM THE CIDPRIT RANDOMIZED CONTROLLED TRIAL. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30DOI:. PMID:. IF:3.200(Q2/4D).
01/06/2025
EFFICACY AND SAFETY OF SUBCUTANEOUS EFGARTIGIMOD PH20 IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: ADHERE/ADHERE plus TRIALS
Allen, JA, Door, PAV, Benedetti, L, Basta, I, Dysgaard, T, Eggers, C, Guptill, JT, Gwathmey, KG, Hewamadduma, C, Hofman, E, Hussain, YM, Kuwabara, S, Le Masson, G, Leypoldt, F, Lin, J, Lipowska, M, Lowe, M, Pinter, GL, Querol, L, Simu, MA, Chang, TN, Tse, A, Ulrichts, P, Van Hoorick, B, Yamasaki, R, Lewis, RA. EFFICACY AND SAFETY OF SUBCUTANEOUS EFGARTIGIMOD PH20 IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: ADHERE/ADHERE plus TRIALS. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30DOI:. PMID:. IF:3.200(Q2/4D).
01/06/2025
Clinical spectrum of anti-IgLON5 disease: A case series with three distinct movement disorder phenotypes
Alberti-Vall, B, Olmedo-Saura, G, Domine, M, Borrell-Pichot, M, Avila, MC, Jordana, AV, Pagonabarraga-Mora, J, Kulisevsky, J, Perez, P. Clinical spectrum of anti-IgLON5 disease: A case series with three distinct movement disorder phenotypes. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025
Fast-track strategy to shorten hospital stay in acute complicated paediatric appendicitis: protocol of the FTAA clinical trial
Leganes, C, Zapata, MJM, Valle, JM, Membrilla, E, Bordon, EA, Palazón, P, Fortes, LM, Núñez, B, Alvarez, N, Pueyo, C, Soria, A, Oviedo, M, Delgado-Espinoza, CE, Antonijoan, RM. Fast-track strategy to shorten hospital stay in acute complicated paediatric appendicitis: protocol of the FTAA clinical trial. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2025; 81(1)DOI:. PMID:. IF:2.700(Q2/5D).
01/06/2025
Non-commercial sponsored clinical trials with medicinal products in Spain since CTIS implementation
Delgado-Espinoza, CE, Garcia, CP, Hosey, KA, Pestana, MJC, Lasso, LFC, Arbos, RMA. Non-commercial sponsored clinical trials with medicinal products in Spain since CTIS implementation. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2025; 81(1)DOI:. PMID:. IF:2.700(Q2/5D).
01/06/2025
Environmental impact of avoidable tertiary care: earth-caring arguments for decentralizing trials
Pontes, C, Cortes, M, Delgado, CE, Castillo, LF, Amaro, K, Torres, F, Antonijoan, RM. Environmental impact of avoidable tertiary care: earth-caring arguments for decentralizing trials. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2025; 81(1)DOI:. PMID:. IF:2.700(Q2/5D).
01/06/2025
Increasing use of gabapentinoids out of their authorised indications
Pontes, C, Cortés, M, de Pando, T, Gomez-Oliveros, B, Antonijoan, RM, Carot-Sans, G, Ramiro, M. Increasing use of gabapentinoids out of their authorised indications. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2025; 81(1)DOI:. PMID:. IF:2.700(Q2/5D).
01/06/2025
Rising alarm on strong opioids in the elderly: a description of utilization and prescription characteristics
Navarro, TDP, Perez, AM, Carot-Sans, G, Martinez, LE, Belis, MV, Nadal, AM, Garcia, CP. Rising alarm on strong opioids in the elderly: a description of utilization and prescription characteristics. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2025; 81(1)DOI:. PMID:. IF:2.700(Q2/5D).
01/06/2025
On the complexity of biomarker-driven diagnoses of Alzheimer's disease
Grasso, SM, Santos-Santos, MA, Clark, AL. On the complexity of biomarker-driven diagnoses of Alzheimer's disease. Journal of Neuropsychology. 2025; 19(2)DOI:10.1111/jnp.12428. PMID:40317662. IF:1.800(Q3/6D).
01/06/2025
City PROFILE: "Barcelona: The experience of 40 years of health reports, a health for all policies tool"
Borrell, C, Carrere, J, Rodríguez-Sanz, M, Gomez-Gutiérrez, A, Daban, F, Pérez, G, Artazcoz, L, Pasarín, MI, Bartoll-Roca, X, Sánchez-Ledesma, E, Serral, G, Mari-Dell'Olmo, M, Montalvo, T, Pérez, K. City PROFILE: "Barcelona: The experience of 40 years of health reports, a health for all policies tool". CITIES. 2025; 161DOI:10.1016/j.cities.2025.105862. PMID:. IF:6.600(Q1/1D).
01/06/2025
Surgical Approach to Hidradenitis Suppurativa
Mateu-Arrom, L, Puig, L, Vilarrasa, E. Surgical Approach to Hidradenitis Suppurativa. Actas Dermo-Sifiliograficas. 2025; 116(6)DOI:10.1016/j.ad.2024.10.061. PMID:40185225. IF:(Q/D).
01/06/2025
The Y chromosome: male reproduction and beyond
Krausz, C, Abrardo, C. The Y chromosome: male reproduction and beyond. FERTILITY AND STERILITY. 2025; 123(6)DOI:10.1016/j.fertnstert.2025.03.006. PMID:40064392. IF:7.000(Q1/1D).
01/06/2025
Expert opinion on a safe same day discharge strategy as standard of care after leadless pacemaker implantation
Somani, R, Daniels, J, Mechulan, A, Paul, V, Sharman, D, Sze, S, Prat, XV. Expert opinion on a safe same day discharge strategy as standard of care after leadless pacemaker implantation. Ijc Heart & Vasculature. 2025; 58DOI:10.1016/j.ijcha.2025.101649. PMID:40170952. IF:(Q/D).
01/06/2025
'Incidence and impact of structural valve deterioration following TAVI: a multicenter real-world study'
Silva, I, Alperi, A, Muñoz, A, Cheema, A, Nombela, L, Veiga-Fernandez, G, Tay, E, Urena, M, Asmarats, L, del Trigo, M, Lim, Y, Alonso, LG, Regueiro, A, Campelo-Parada, F, Serra, V, del Val, D, Ribeiro, HB, Ternacle, J, Vilalta, V, Vidal, P, Belahnech, Y, Alfonso, F, Nuche, J, Rodes-Cabau, J, Pibarot, P. 'Incidence and impact of structural valve deterioration following TAVI: a multicenter real-world study'. European Heart Journal-Cardiovascular Imaging. 2025; 26(6)DOI:10.1093/ehjci/jeaf083. PMID:40059432. IF:6.600(Q1/1D).
01/06/2025
Salt repletion and diuretic response: The role of serum chloride. A post-hoc analysis of the SALT-HF trial on furosemide and hypertonic saline solution administration in ambulatory patients with worsening heart failure
Núñez, J, Miñana, G, de la Espriella, R, Zegrí-Reiriz, I, Comín-Colet, J, Gracia, JR, Morales-Rull, JL, Llàcer, P, Diez-Villanueva, P, Bagudá, JD, Cortes, Cé, Goirigolzarri-Artaza, J, García-Pinilla, JM, Barrios, E, Díaz, SD, Jiménez-Marrero, S, Restrepo-Córdoba, MA, Testani, J, Marcos, MC. Salt repletion and diuretic response: The role of serum chloride. A post-hoc analysis of the SALT-HF trial on furosemide and hypertonic saline solution administration in ambulatory patients with worsening heart failure. EUROPEAN JOURNAL OF HEART FAILURE. 2025; 27(6)DOI:10.1002/ejhf.3597. PMID:39933832. IF:10.800(Q1/1D).
01/06/2025
Impact of left ventricular unloading on postheart transplantation outcomes in patients bridged with VA-ECMO
Enríquez-Vázquez, D, Barge-Caballero, E, González-Vílchez, F, Almenar-Bonet, L, Carmena, MDGC, González-Costello, J, Gómez-Bueno, M, Castel-Lavilla, MA, Díaz-Molina, B, Martínez-Sellés, M, Mirabet-Pérez, S, de la Fuente-Galán, L, Hervás-Sotomayor, D, Rangel-Sousa, D, Garrido-Bravo, IP, Blasco-Peiró, T, Juan-Aracil, GR, Muñiz, J, Crespo-Leiroa, MG. Impact of left ventricular unloading on postheart transplantation outcomes in patients bridged with VA-ECMO. REVISTA ESPANOLA DE CARDIOLOGIA. 2025; 78(6)DOI:10.1016/j.rec.2024.09.005. PMID:39393768. IF:4.900(Q1/2D).
01/06/2025
Biomarkers of inflammation and coagulation predict non-AIDS-defining events in a prospective cohort of virologically suppressed people living with HIV
Saumoy, M, Fernandez, A, Tiraboschi, J, Peñafiel, J, Sánchez-Quesada, JL, Vega, J, García, B, Soriano, I, Podzamczer, D, Imaz, A. Biomarkers of inflammation and coagulation predict non-AIDS-defining events in a prospective cohort of virologically suppressed people living with HIV. HIV MEDICINE. 2025; 26(6)DOI:10.1111/hiv.70017. PMID:40130659. IF:3.200(Q2/4D).
01/06/2025
RACE/ETHNICITY AND RHEUMATOID ARTHRITIS SEVERITY IN THE CONTEXT OF AN ACCESSIBLE PUBLIC HEALTHCARE SYSTEM
Ruiz-Esquide, V, Roig-Vilaseca, D, Mateo-Soria, L, Pérez, SH, Nack, A, Perez-Garcia, C, Park, HS, Paños, HB, Gómez-Puerta, JA, Sanmarti, R. RACE/ETHNICITY AND RHEUMATOID ARTHRITIS SEVERITY IN THE CONTEXT OF AN ACCESSIBLE PUBLIC HEALTHCARE SYSTEM. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B2454. PMID:. IF:20.600(Q1/1D).
01/06/2025
Pituitary Apoplexy: Comorbidities, Management, and Outcomes-A Spanish Observational Multicenter Study
Biagetti, B, Asanza, EC, Pérez-López, C, Araujo-Castro, M, Camara, R, Guerrero-Pérez, F, Vicente, A, Lamas, C, Serra, G, Echarri, AI, Ollero, MD, Molero, IG, Villar-Taibo, R, Rodríguez, MDM, Garcia-Feijoo, P, Berrocal, VR, Ramirez, MNS, Hurtado, AG, Capristan-Díaz, V, Simó-Servat, A, Gallach, M, Perez, ES, Rosa, VG, Civantos, S, Asensio-Wandosell, D, Martinez-Saez, E, Torre, EM, Aulinas, A, Iglesias, P, Diez, JJ, Bernábeu, I, Alvarez-Escolá, C, Puig-Domingo, M. Pituitary Apoplexy: Comorbidities, Management, and Outcomes-A Spanish Observational Multicenter Study. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2025; 110(6)DOI:10.1210/clinem/dgae649. PMID:39298667. IF:5.100(Q1/2D).
01/06/2025
Predictors of conversion to surgery in pituitary apoplexy: Insights from a Spanish multicenter observational study
Biagetti, B, Asanza, EC, Pérez-López, C, Berrocal, VR, Vicente, A, Lamas, C, Guerrero-Pérez, F, Simó-Servat, A, Serra, G, Echarri, AI, Ollero, MD, Molero, IG, Villar-Taibo, R, Rodríguez, MDM, García-Feijoo, P, Ramirez, MNS, Hurtado, AG, Capristan-Díaz, V, Camara, R, Gallach, M, Perez, ES, Rosa, VG, Civantos-Modino, S, Martinez-Saez, E, Torre, EM, Aulinas, A, Iglesias, P, Diez, JJ, Bernabéu, I, Alvarez-Escolá, C, Puig-Domingo, M, Araujo-Castro, M. Predictors of conversion to surgery in pituitary apoplexy: Insights from a Spanish multicenter observational study. Journal Of Clinical And Translational Endocrinology. 2025; 40DOI:10.1016/j.jcte.2025.100399. PMID:40486975. IF:(Q/D).
01/06/2025
Diagnosis and Management of Early Stages of ALD
Gratacós-Ginés, J, Alvarado-Tapias, E, Martí-Aguado, D, López-Pelayo, H, Bataller, R, Pose, E. Diagnosis and Management of Early Stages of ALD. SEMINARS IN LIVER DISEASE. 2025; 45(02)DOI:10.1055/a-2541-2892. PMID:39965759. IF:3.700(Q2/3D).
01/06/2025
Core domain set for chronic and/or recurrent manifestations of calcium pyrophosphate deposition disease: OMERACT delphi survey to establish consensus
Zhang, YL, Tedeschi, SK, Abhishek, A, Hensey, O, Grossberg, D, Cai, K, Shea, B, Singh, JA, Christensen, R, Serban, T, Cipolletta, E, Parperis, K, Diaz-Torne, C, Mccarthy, GM, Becce, F, Gheita, TA, Sirotti, S, Christiansen, SN, Coronel, L, Stamp, LK, Abdel-Fattah, YH, Pascart, T, Filippou, G, Hong, LE, Fitzgerald, J, Dalbeth, N. Core domain set for chronic and/or recurrent manifestations of calcium pyrophosphate deposition disease: OMERACT delphi survey to establish consensus. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2025; 72DOI:10.1016/j.semarthrit.2025.152669. PMID:40086154. IF:4.400(Q1/1D).